Team:EPF Lausanne/Calendar/1 August 2013

From 2013.igem.org

(Difference between revisions)
 
(One intermediate revision not shown)
Line 1: Line 1:
{{Template:EPFL2013Header}}
{{Template:EPFL2013Header}}
-
'''Cell Surface Display'''
+
<font size = "4">Cell Surface Display</font>
''Gibson Assembly ''  
''Gibson Assembly ''  
Line 6: Line 6:
<br>-Gibson Assembly from the DpnI digested products (see under protocols).
<br>-Gibson Assembly from the DpnI digested products (see under protocols).
<br> -Gel electrophoresis to verify the Gibson product.
<br> -Gel electrophoresis to verify the Gibson product.
 +
<BR>
-
'''Nanoparticles''' <BR>
+
 
 +
<font size = "4">Nanoparticles</font>
''Making nanoparticles 1st try'' <br>  
''Making nanoparticles 1st try'' <br>  

Latest revision as of 14:40, 3 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Cell Surface Display

Gibson Assembly
-We did the DpnI digestion of our previous PCR products (streptavidin dead and INP_construct) to remove any carry over of the original plasmids.
-Gibson Assembly from the DpnI digested products (see under protocols).
-Gel electrophoresis to verify the Gibson product.


Nanoparticles

Making nanoparticles 1st try
We did the second cross-linking step with glutaraldehyde of the GPs+dye.